DFMCH Vice-Chair for Research, David Rabago, MD, presented the abstracts of three prolotherapy studies at the elite North American Primary Care Research Group (NAPCRG) conference in Chicago, IL, in November 2018.  Two of the three won prestigious Pearl Awards; both were selected from over 1000 peer-reviewed abstracts as those “most likely to influence clinical practice”.

David Rabago, MD

David Rabago, MD

The abstracts presented as podium presentations that won PEARL awards included:

  • Intra-Articular Hypertonic Dextrose Prolotherapy Reduces Knee Pain in Knee Osteoarthritis: A One Year Blinded Randomized Controlled Trial
  • Prolotherapy, Physiotherapy and Combination Care for Lateral Epicondylalgia: A 3-Arm Single-Blinded Randomized Clinical Trial

A third abstract was presented as a poster:

  • Dextrose prolotherapy for knee OA in routine clinical practice: Self-reported and objectively-assessed outcomes in a feasibility study

The NAPCRG annual conference brings together clinicians, scientists, students, and patients from around the world to share and discuss primary care research.  This year, seven DFMCH faculty and staff will attend the conference in Toronto, Canada, and three will give presentations.

This Year’s Presenters

Bruce Barrett, MD, PhD (Podium Presentation)
Mindfulness Meditation and Exercise Each Improve Sleep Quality in Adults Without Known Sleep Problems: a Randomized Trial.

Andrew Quanbeck, PhD (Podium Presentation)
Using Stakeholder Values to Promote Implementation of an Evidence-Based mHealth Intervention for Addiction Treatment in Primary Care.

Nicholas Schumacher (Poster Presentation)
Implementing Shared Decision Making for Cancer Screening Using Decision Aids in Electronic Health Records in Primary Care.

Published: November 2019